Diabetes in Society

English

Prevention of diabetes throughout an obesogenic world

Overweight is an important risk factor for noncommunicable diseases in general and diabetes in particular. There is presently a global epidemic of overweight. A recent large study found a 5.6% growth in obesity in the United States in 2001, and a massive 74% increase since 1991. Twenty one percent of American adults are obese. The prevalence of diabetes, which correlates with obesity has risen 61% in the US since 1990. Diabetes rose 8% over 2000-01 to nearly 8% of the population. The situation is not much better in many developing countries.

The obesity campaign view of diabetes prevention

Obesity is an epidemic accelerating out of control. It is the driving force behind an equally dramatic explosion of Type 2 diabetes, both in adults and now alarmingly among children. Clearly, strategies aimed at improving the prevention and management of obesity must be developed. Not confined to affluent nations, the obesity epidemic imposes a double burden on countries where people are still struggling to overcome generations of chronic undernutrition. Economic progress in developing countries heralds changes in

The diabetes epidemic in full flight: forecasting the future

Were there warnings that diabetes would become the epidemic of the 21st century? In the early 1970s, Peter Bennett and co-workers reported on the extraordinarily high prevalence of Type 2 diabetes in Pima Native Americans. In 1975, we reported the high rates of diabetes in the Micronesian Nauruans in the Pacific. Similar findings followed in other Pacific and Asian island populations. They all indicated the potential for a future global epidemic.

Diabetes Action Now: WHO and IDF working together to raise awareness worldwide

Even among policy makers at an international and national level, awareness about the public health and clinical importance of diabetes remains low. Diabetes is widely perceived as a condition of low importance to the poorer populations in the world. In the low- and middle-income countries, the impact of diabetes is largely unrecognized. Yet the world is facing a dramatic rise in diabetes prevalence, most of which will occur in the low- and middle-income countries.

Diabetes and the World Health Organization

The aim of the World Health Organization (WHO) is the achievement of the highest possible level of health for all the world's people. From its global headquarters in Geneva and its Regional Offices, it assists national governments achieve this aim by setting international norms and standards, and providing leadership and technical support. WHO has substantial influence and prestige and has several major accomplishments to its credit, most notably the global eradication of smallpox in 1979, and major reductions in the burden of polio, leprosy, river blindness and tuberculosis.

WDF and diabetes care in Tanzania: making a difference

The World Diabetes Foundation (WDF) is dedicated to supporting prevention and management of diabetes in the developing world. Accordingly it funds sustainable projects in education, capacity building, and distribution and procurement of essential medical supplies. WDF creates partnerships and acts as a catalyst to help others

Better product information: is direct advertising the answer?

In the last few years, there has been an important but little-publicized

The cost of kidney disease in India: one person's story

India is fast-becoming the diabetes capital of the world. More than 35.5 million people in India now have diabetes. This figure is likely to rise to 57 million by 2025. This increase, principally in people with Type 2 diabetes, is bringing with it a sharp growth in diabetic complications, including eye disease (retinopathy) and kidney disease (nephropathy). In this report, Ambady Ramachandran describes the costs of diabetes and kidney disease to a person in India

The costs of kidney disease

Existing and recent health-care interventions have the potential to reduce the economic impact of diabetes complications, including kidney (renal) disease. In this article, Thomas Songer provides a brief overview of current understanding regarding the costs related to kidney disease.

Diabetic kidney disease in disadvantaged people

A rising frequency of diabetic kidney disease worldwide is disproportionately affecting disadvantaged people. Among the hardest hit are people in the poorest countries, which lack the public health infrastructure to address the epidemic using treatments widely available in the developed world. In this article, Robert Nelson examines the frequency of diabetic kidney disease in various parts of the world, explores some reasons why disadvantaged populations may be particularly vulnerable to this complication of diabetes, and describes how health-care providers may successfully

Pages